NDAORALTABLET
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
GLYSET (miglitol) by Pfizer is alpha glucosidase inhibitors [moa]. First approved in 1996.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GLYSET (miglitol) is an alpha-glucosidase inhibitor oral tablet approved in 1996 for type 2 diabetes management. It works by slowing carbohydrate digestion and glucose absorption in the small intestine, reducing postprandial blood sugar spikes. This small-molecule agent is typically used as adjunctive therapy alongside diet and exercise or other antidiabetic agents.
LOE Approaching
Product is in mature/late lifecycle stage with moderate competitive pressure (30%), indicating smaller team size and focus on cost management rather than growth initiatives.
Mechanism of Action
alpha Glucosidase Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (7)
A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol
Started Feb 2010
30 enrolled
Healthy VolunteersPharmacokinetics of ASP1941
Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Type 2 Diabetes Mellitus
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Type 1 Diabetes Mellitus
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
Type 2 Diabetes Mellitus
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
Type 2 Diabetes Mellitus
Worked on GLYSET at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.